Cite
HARVARD Citation
Sharpley, F. et al. (2020). Clinical outcomes with fixed-duration therapy (UK real-world data) compared with continuous lenalidomide and low-dose dexamethasone therapy (FIRST trial; MM-020) for transplant-ineligible patients with newly-diagnosed multiple myeloma. Leukemia & lymphoma. 61 (3), pp. 732-736. [Online].